pirical therapy. This widespread injudicious use diminishes the efficacy of affordable and available drugs, which poses a serious problem when antimicrobial treatment is needed [1] . Overuse of antimicrobials also wastes limited financial resources on ineffective medications that expose patients unnecessarily to potential toxicities, may prolong illness, and can increase risk of death [2] . Understanding prevalent antimicrobial susceptibility patterns could inform guidelines for empirical therapy to reduce injudicious antimicrobial use and thereby preserve the utility of available medicines by limiting the development of antimicrobial resistance.
Following an outbreak of Shigella dysenteriae type 1 infection in rural western Kenya during the mid-1990s [3] , we established surveillance for bacterial causes of diarrheal illness in this area. The project was a collaboration between the Kenya Medical Research Institute and the Centers for Disease Control and Prevention. Here, we report the results of 6 years of surveillance.
Results from the first year of this surveillance project have been reported previously [4] .
METHODS
Study site. We established clinic-based sentinel surveillance for bacterial diarrheal illness in Asembo Bay, a rural community bordering Lake Victoria in the Nyanza Province, Kenya. In 2003, 87.6% of households in this region lacked access to safe potable water, and 26.2% of households lacked any means other than open defecation for disposal of human waste [5] . This province also has one of the nation's lowest immunization rates [5, 6] , the highest infant and child mortality rates [5, 6] , and the highest officially reported HIV prevalence (15% among persons aged 15-49 years in 2000 [5] ). Other endemic diseases include malaria, tuberculosis, and schistosomiasis; malnutrition is common.
Surveillance and specimen collection. From 1 May 1997 to 30 April 2003, we conducted surveillance for bacterial causes of diarrheal illness at 2 rural government health clinics and the outpatient clinic of a mission hospital. On 1 September 1997, a fourth surveillance site was added at a private clinic. The clinics treated both adults and children, capturing 20% of outpatient visits for diarrhea in the catchment area [7] . Persons presenting with diarrhea (defined as у3 bowel movements in any 24-h period during the preceding 5 days) were offered enrollment. Laboratory capacity permitted analysis of up to 5 stool samples daily from each clinic. Stool culture was not otherwise available in the region and was offered at no cost to encourage capture of all diarrheal illnesses in our surveillance clinics; periodic review of clinic records indicated that 180% of persons presenting with sporadic diarrhea were enrolled.
Using standardized forms, trained field staff collected the following from each patient: demographic information, illness symptoms, medications taken before the visit, medications prescribed at the visit, and a stool specimen (either whole stool or a Dacron rectal swab). Supervisors reviewed all forms for errors and provided feedback. We defined diarrhea as bloody if blood was visible in the specimen or if the patient or their caretaker reported seeing blood in their stool. Diarrhea not defined as bloody was categorized as watery or mucoid, according to patient report.
Swabs of whole stool specimens and rectal swabs were placed immediately in Cary-Blair transport medium and cooled to 4Њ-8ЊC in insulated containers that were stocked daily with fresh ice packs and monitored for temperature. Most specimens were transported to the Kenya Medical Research Institute/Centers for Disease Control and Prevention Enterics Laboratory (Kisumu, Kenya) and were processed on the day of collection; the maximum time permitted between collection and processing was 36 h. We reported the results of bacterial cultures and antimicrobial susceptibility testing to surveillance clinic staff.
Laboratory procedures. All stool specimens were cultured for Shigella, Salmonella, Vibrio, and Campylobacter species. Pathogens were isolated and identified by standard methods. We determined serotypes of Shigella flexneri and nontyphoidal Salmonella isolates; we also determined whether Vibrio cholerae isolates were serogroup O1 using commercial antisera [8] . Sweeps of the bacterial growth on MacConkey agar plates were preserved at Ϫ70ЊC in tryptic soy broth with glycerol, and a random subset was probed by PCR to detect the following diarrheagenic Escherichia coli virulence factors: Shiga toxins 1 and 2 (stx 1 and stx 2 ) [9] , intimin (eae) [10] , enterohemolysin (E-hly) [11] , heat-labile and heat-stable enterotoxins [12] , invasion plasmid antigen (ipaH) [13] , enteropathogenic E. coli adherence factor (EAF plasmid) [14] , and the enteroaggregative E. coli plasmid CVD432 (aatA) [15] .
We determined antimicrobial susceptibilities of Shigella, Salmonella, and Vibrio isolates to a panel of 12 antibiotics (table  1) by the Kirby-Bauer disk diffusion method [16] . We tested a randomly selected subset of Campylobacter isolates by the Etest method (AB Biodisk) [17] for susceptibility to a panel of 8 antibiotics (table 2) . We classified isolates with moderate or intermediate susceptibility as susceptible in analysis.
Statistical methods. Data were analyzed using SAS software, version 8.0 (SAS Institute). Incidence rates were calculated by dividing the number of outcomes by the total at-risk population enrolled in our surveillance system. Relative risks were calculated using the x 2 method or Fisher's exact test; 2-tailed P values !.05 were considered to be statistically significant. The x 2 test for trend was considered to be statistically significant if the P value was !.05. Positive predictive values were considered to be clinically meaningful if they were у70%. Correlation coefficients were calculated by the Spearman rankcorrelation method.
Scientific ethics. The investigation followed the guidelines 
RESULTS
Specimen and population characteristics. During 6 years of surveillance, 3445 total specimens were collected from persons with diarrhea; 756 (22%) from persons with bloody diarrheal illnesses, 2028 (59%) from persons with watery diarrheal illnesses, 527 (15%) from persons with mucoid diarrheal illnesses; and 134 (4%) from persons with uncharacterized diarrheal illnesses (table 3) . Two outbreaks of infection with V. cholerae serogroup O1 were detected during the surveillance period, the first during September-October 1997 [18] and the second during January-February 1999. The median participant age was 19 years (interquartile range, 1.6-33 years), and 52% of the participants were female (table  3) . Children aged !5 years provided 36% of specimens (figure 1). Patients presented to health centers a median of 3 days after diarrhea onset (interquartile range, 2-5 days). Illness symptoms included abdominal cramping (in 80% of patients), subjective fever (76%), nausea (60%), and vomiting (46%). Nausea, vomiting, and abdominal cramping were reported statistically more often for persons with watery diarrhea ( , , and P ! .01 P ! .01 , respectively); otherwise, duration of diarrhea before P p .03 presentation to the health center and symptoms were similar for patients with the different types of diarrhea (table 3) .
Bacterial isolates. We isolated no bacterial pathogen from 2353 specimens (68.3%): 19 specimens (0.5%) produced no bacterial growth, and 2334 (67.8%) grew nonpathogenic bacteria. Overall, 1092 specimens (31.7%) yielded at least 1 path- (9) 78 (15) 9 (7) Shigella flexneri 298 (9) 149 (20) 99 (5) 45 (8) 5 (4) Shigella dysenteriae type 1 55 (2) 44 (6) 
Shigella dysenteriae, other 100 (3) 53 (7) 35 (2) 12 (2) 0 (0) Shigella boydii 51 (1) 21 (3) 18 (1) 10 (2) 2 (1) (5) 31 (4) 115 (6) 20 (4) 7 (5) Group B Salmonella
Other Vibrio species 2 (!1) (8) 46 (6) 194 (9) 41 (8) 13 (10) NOTE. IQR, interquartile range. a Reported "bloody diarrhea" but may also have reported "watery" and/or "mucoid diarrhea." b Reported "watery diarrhea" but denied having "bloody diarrhea." Unknown responses for "bloody diarrhea" were excluded. c Reported "mucoid diarrhea" alone and denied having both "bloody" and "watery diarrhea." Unknown responses for "bloody diarrhea" and for "watery diarrhea" were excluded.
ogen: 1033 specimens (30.0%) yielded a single pathogen, and 59 specimens (1.7%) yielded 11 pathogen (table 3) . Isolation rates were greater for specimens from patients with bloody diarrhea (46%) than for specimens from patients with watery (29%), mucoid (25%), or uncharacterized diarrhea (22%) (table 3 pathogenic (eae and EAF), 4 as enteroinvasive (ipaH), and 1 as non-O157 Shiga toxin-producing E. coli (stx 1 ). For 43 (72%) of these specimens, diarrheagenic E. coli was the sole pathogen identified. Probing for diarrheagenic E. coli increased the overall specimen yield by 6%.
For analysis of sporadic illness, we excluded 117 cases of cholera attributable to V. cholerae O1 during known outbreaks. Among those sporadic illnesses for which a single pathogen was isolated that could, therefore, be considered the definitive cause, 56% were caused by Shigella species (30% were caused by S. flexneri), 27% were caused by Campylobacter species, 16% were caused by nontyphoidal Salmonella, and 1% were caused by Vibrio species or S. Typhi. The distribution of pathogens varied according to the type of diarrhea (table 3) . Projecting the comparable proportions to include the results from probing a subset of specimens for diarrheagenic E. coli, we estimated that 25% of illnesses were caused by S. flexneri, 22% were caused by other Shigella species, 20% were caused by Campylobacter species, 20% were caused by diarrheagenic E. coli, 12% were caused by nontyphoidal Salmonella, and 1% was caused by Vibrio species or S. Typhi (figure 2). Among children aged !5 years, the most frequently isolated pathogens were Campylobacter species (42%) and diarrheagenic E. coli (34%), whereas in persons aged у5 years, the most common pathogens were Shigella species (65%). Predominating serotypes of nontyphoidal Salmonella and Shigella flexneri are shown in table 4.
Age-specific isolation rates varied significantly by pathogen ( figure 3) . Rates of campylobacteriosis were greatest among persons aged !5 years and decreased progressively with increasing age, whereas shigellosis rates were lowest among children and increased progressively with increasing age (P ! .001 for both trends by x 2 test) (figure 3). The age-specific isolation rates for diarrheagenic E. coli, calculated from the subset of screened samples mimicked the pattern for Campylobacter species, with the exception of a notable increase in young adults 18-39 years old.
Associations with presenting signs and symptoms. Shigella species were significantly more likely to be isolated from patients with bloody diarrhea (relative risk, 3.74;
) and P ! .001 patients with mucoid diarrhea (relative risk, 1.35; ) P p .004 and nontyphoidal Salmonella was significantly more likely to be isolated from patients with watery diarrhea (relative risk, 1.48; ) at times other than during cholera outbreaks. P p .03 Isolation of Campylobacter species was not associated with type of diarrhea, neither in the total population nor when stratified by age group (!5 years or у5 years). Positive predictive values у70% were noted for isolating Shigella species from bloody diarrhea (for all ages) and from mucoid diarrhea (for patients aged у5 years). No other types of diarrhea, other symptoms, or other symptom complexes had a positive predictive value у70% for any pathogen.
Diarrheal treatment, antimicrobial use, and susceptibility testing. Before the clinic visit, 2066 persons with diarrhea (60%) took some form of medicine, which, in 1005 instances (29%) was an antimicrobial and in 784 instances (23%) was an antimicrobial active against enteric gram-negative rods (GNRs) (table 5). One-hundred and six patients (3.1%) took oral rehydration solution before the clinic visit: 48 (3.8% of the children) !5 years old and 58 (2.7% of the patients) у5 years old ( ). At the time of clinic visit, 2630 persons P p .05 with diarrhea (76%) were prescribed treatment; an antimicrobial was prescribed in 2302 instances (67%), and an antimicrobial active against GNRs was prescribed in 1776 instances (52%). Children aged !5 years were significantly more likely to receive treatment at the clinic visit (84% vs. 73% of persons у5 years old; ), including treatment with an antimi-P ! .001 crobial (70% vs. 65%; ) but not with an antimicrobial P p .010 active against GNRs (53% vs. 51%;
). Children were P p .373 also significantly more likely to be prescribed oral rehydration The antimicrobial prescribed most frequently for diarrhea was metronidazole (in 14% of cases). For the antimicrobials active against GNRs that were prescribed most frequently, susceptibilities of Shigella, nontyphoidal Salmonella, and Vibrio species were low (trimethoprim-sulfamethoxazole, 14%; ampicillin, 41%; amoxicillin-clavulanate [prescribed for only 5 illnesses], 65%; and tetracycline, 29%; table 1). Susceptibilities to kanamycin, gentamicin, ciprofloxacin, and ceftriaxone were 195%; all were used infrequently or were unavailable in the community. The frequency with which antimicrobials active against GNRs were prescribed correlated highly with resistance among Shigella and nontyphoidal Salmonella isolates (Spearman rank-correlation, Ϫ0.74;
; figure 4 ). Similar cor-P p .035 relations were not observed with Vibrio or Campylobacter species.
Susceptibilities of Campylobacter species to the antimicrobials tested were 180% except for trimethoprim-sulfamethoxazole (72%) and nalidixic acid (75%) (table 2). However, almost one-half (48%) of isolates demonstrated only intermediate susceptibility (MIC, 1-4 mg/mL) to erythromycin. C. coli, which accounted for 18% of speciated and tested Campylobacter isolates, demonstrated notably reduced susceptibility to nalidixic acid (20%).
Using data from 468 persons from whom a pathogen was isolated for which antimicrobial susceptibility was determined (including Campylobacter species) and who were prescribed an antimicrobial, 249 (53%) received only antimicrobials to which their isolate was not susceptible. The low susceptibility of S. flexneri and S. dysenteriae to the antimicrobials most often prescribed, which was noted during the first year of surveillance [7] , continued throughout subsequent years, as did the comparably low susceptibility of the predominant nontyphoidal Salmonella serotype, Salmonella enterica serotype Enteritidis.
DISCUSSION
In this rural sub-Saharan African community, Shigella speciesparticularly S. flexneri-predominated as a cause of sporadic bacterial diarrheal illness. The principal pathogens causing illness varied considerably by age, with children !5 years old affected disproportionately by Campylobacter species and diarrheagenic E. coli. The causes of bacterial diarrhea that we identified in our clinic-based surveillance and their proportional distribution by age are generally consistent with the findings of prior reports [19, 20] , and we believe that the community where we conducted surveillance is likely representative of many rural sub-Saharan regions of Africa with regard to established risks for diarrhea and patterns of antimicrobial use. The high prevalence of HIV infection, particularly among young adults, may limit the generalizability of these findings. The bimodal peak in diarrheal illness incidence that included young adults and the increased isolation rate of diarrheagenic E. coli that we observed in persons 18-39 years old may reflect the effect of HIV disease, an established risk factor for infection with these bacteria [21] [22] [23] [24] [25] . The increased rates of shigellosis that we identified in adults may reflect both the effects of prevalent HIV infection and possible selection bias, whereby only adults with severe diarrheal disease (such as bloody diarrhea, for which Shigella species are the most common pathogens in this region [4] ) sought care and were thus captured in our surveillance.
We measured high and persistent levels of resistance to the antimicrobials prescribed most commonly and found that decreased susceptibility of Shigella and nontyphoidal Salmonella correlated strongly with local antimicrobial pressure, as approximated by frequency of clinic prescriptions for diarrheal illness. In addition to remediating established risks for diarrhea in this community (e.g., providing safe drinking water and improving hygienic disposal of human waste), improving antimicrobial prescription practices and limiting unregulated availability of antimicrobials are secondary prevention strategies that warrant consideration.
We found minimal resistance to fluoroquinolones and nalidixic acid, oral alternatives to existing antimicrobials. For shigellosis, a major bacterial cause of bloody diarrhea, recent World Health Organization guidelines recommend treatment with fluoroquinolones [26] . We urge judicious, controlled use of fluoroquinolones for adults with clinically significant sporadic bloody diarrhea and persons at increased risk of prolonged illness, complications, or death from bacterial diarrhea (e.g., persons with AIDS). For children, nalidixic acid may be a safer, yet equally effective, empirical choice than fluoroquinolones in instances in which resistance among Shigella isolates remains low. We caution against widespread use of fluoroquinolones for all-cause diarrhea in regions comparable to our field research area, and we support efforts to restrict retail availability of these agents to the public. Although susceptibilities to available medications may be decreased, most cases of uncomplicated (i.e., nonbloody) sporadic diarrhea do not require antimicrobial therapy and resolve with symptomatic support (e.g., oral rehydration).
Metronidazole was the antimicrobial prescribed most fre-quently for diarrhea, and it was given twice as often as the second most frequently prescribed antimicrobial, trimethoprim-sulfamethoxazole. Metronidazole was given significantly more often to adults and children with bloody diarrhea (P ! ), suggesting that it may be used in this community as .001 empirical therapy for parasitic dysentery (e.g., amoebiasis). Cross-sectional and additional prospective study data from this region indicate that amoebiasis, giardiasis, and Clostridium difficile toxin-mediated illness likely account for !1% of cases of diarrhea [27] (J.T.B., J.B.O., T.G., M.B., C.B., M. Wilson, unpublished data). Metronidazole has no gram-negative activity and can cause clinically important adverse events (e.g., disulfiram-like reaction exacerbated by alcohol and peripheral neuropathy).
Our data reflect the prevalence of bacterial diarrheal illness among persons seeking care, which may not represent the burden of disease in the community at large. Our clinic-based population had more than twice as many children age !5 years than did the catchment area's general population [28] , which likely reflects the greater burden of diarrheal illness in young children, for whom the threshold for seeking clinical evaluation was likely lower. Our clinic-based population also had a greater number of young adults, which we believe may result from the disproportionate burden of HIV infection and associated diarrheal illness in this age group. We used Cary-Blair medium instead of buffered glycerol saline (a liquid medium) to collect stool swabs, because this semisolid material can be stored for prolonged periods at room temperature. The decreased recovery of Shigella and possibly other bacteria with Cary-Blair medium was a practical compromise that we believe did not affect our estimates of the proportional contribution of different enteric bacteria to diarrheal illness but may have somewhat underestimated the true burden of disease among persons captured in our surveillance system. The participants' major complaint was diarrhea, although some may have received diagnoses and treatment for other illnesses. We did not determine participants' courses of diarrheal illness and the clinical impact of treatment. We also did not screen stool samples from a comparable control population to assess the extent of asymptomatic carriage of bacteria to which we attributed illness-an issue of some controversy, depending on the bacteria and the population studied (e.g., enteroaggregative E. coli in children). Lastly, antimicrobial use prior to clinic presentation was subject to recall bias (1-5 days for most participants), and we could not assess whether prescribed medications were actually obtained or taken.
In summary, Shigella species, particularly S. flexneri, cause most bacterial diarrhea in rural western Kenya, but Campylobacter species account for a large fraction of illnesses in children !5 years old. There is substantial and persistent antimicrobial resistance among prevalent pathogens to the antimicrobials most frequently prescribed for diarrhea in the community, and many persons receive inappropriate medications. Improving hygiene, providing safe potable water, and developing vaccines are public health priorities that, together with more judicious use of antimicrobials, could preserve antimicrobial efficacy and substantially reduce diarrheal illness. Further research is needed to unravel the puzzle of why antibiotics are prescribed in the manner that we observed and to identify avenues for improving the level of informed and beneficial use.
